Open-label Extension to Protocol 1042-0600

Summary

Open-label Extension to Protocol 1042-0600 is a clinical trial^[1].

Key Facts

• Open-label Extension to Protocol 1042-0600 is in the country of United States^[2].
• Open-label Extension to Protocol 1042-0600's instance of is recorded as clinical trial^[3].
• Open-label Extension to Protocol 1042-0600's start time is recorded as +2007-06-30T00:00:00Z^[4].
• Open-label Extension to Protocol 1042-0600's end time is recorded as +2009-12-31T00:00:00Z^[5].
• Open-label Extension to Protocol 1042-0600's sponsor is recorded as Marinus Pharmaceuticals (United States)^[6].
• Open-label Extension to Protocol 1042-0600's main subject is recorded as epilepsy^[7].
• Open-label Extension to Protocol 1042-0600's number of participants is recorded as {'unit': '1', 'amount': '+125'}^[8].
• Open-label Extension to Protocol 1042-0600's title is recorded as An Open-label Extension Study to Evaluate the Safety, Tolerability, and Efficacy of Ganaxolone as add-on Therapy in Adult Patients With Epilepsy Consisting of Uncontrolled Partial-onset Seizures.^[9].
• Open-label Extension to Protocol 1042-0600's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[10].
• Open-label Extension to Protocol 1042-0600's ClinicalTrials.gov ID is recorded as NCT00512317^[11].
• Open-label Extension to Protocol 1042-0600's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+69'}^[12].
• Open-label Extension to Protocol 1042-0600's research intervention is recorded as pregnanolone^[13].
• Open-label Extension to Protocol 1042-0600's clinical trial phase is recorded as phase II clinical trial^[14].
• Open-label Extension to Protocol 1042-0600's research site is recorded as University of Alabama^[15].
• Open-label Extension to Protocol 1042-0600's research site is recorded as Barrow Neurological Institute^[16].
• Open-label Extension to Protocol 1042-0600's research site is recorded as Emory University^[17].
• Open-label Extension to Protocol 1042-0600's research site is recorded as Thomas Jefferson University^[18].
• Open-label Extension to Protocol 1042-0600's research site is recorded as Mid Atlantic Epilepsy and Sleep Center^[19].
• Open-label Extension to Protocol 1042-0600's research site is recorded as University at Buffalo^[20].
• Open-label Extension to Protocol 1042-0600's research site is recorded as Vanderbilt University Medical Center^[21].
• Open-label Extension to Protocol 1042-0600's research site is recorded as Virginia Commonwealth University^[22].
• Open-label Extension to Protocol 1042-0600's research subject recruitment status is recorded as completed^[23].
• Open-label Extension to Protocol 1042-0600's study type is recorded as interventional study^[24].